drugset / Trial / NCT04444050

Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986331 in Healthy Participants

NCT04444050 ↗

Phase 1 Completed 48 enrolled Bristol-Myers Squibb
RandomizedSequentialTriple-blindBasic science

Summary

The purpose of this study is to evaluate the safety, tolerability, drug levels and drug effects of single and multiple oral doses of BMS-986331 versus placebo in healthy participants and healthy Japanese participants.

Timeline

Start
2020-06-23
Primary completion
2021-05-19
Completion
2021-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986331 Unknown — Oral

Indications

No indication recorded.